December 11 – 12, 2025
2F, Grand Ballroom, Daejeon Convention Center 1 (DCC 1),
Daejeon, South Korea
Welcome to the IBS-KAI-KSV Conference on
Infection and Immunity
“IBS-KAI-KSV Conference on Infection and Immunity” aims to bring together professionals and experts from various fields to exchange ideas, insights, and experiences on Infection and Immunity area. With a diverse range of speakers, interactive sessions, and networking opportunities, the conference promises to be both informative and engaging.
Date & Venue
December 11th – 12th, 2025
2F, Grand Ballroom ,Daejeon Convention Center 1 (DCC 1), Daejeon, South Korea
Program
| Time | Program |
|---|---|
| 08:30-09:20 | Registration |
| 09:20-09:30 | Opening Remarks |
| Symposium 1 / Chairs: Dr. Richard Webby , Dr. Nam-hyuk Cho | |
| 09:30-10:10 | Dr. Peiris, Joseph Sriyal Malik (The University of Hong Kong, China) Pandemic threats from coronaviruses |
| 10:10-10:40 | Dr. Atsushi Kawaguchi (University of Tsukuba, Japan) Molecular basis of SARS-CoV-2 multiorgan infection via viremia |
| 10:40-11:10 | Dr. Young Ki Choi (Korea Virus Research Institute, IBS, Korea) Animal organoid model systems and their applications for studying of emerging and re-emerging viruses |
| 11:10-11:40 | Dr. Sangjoon Lee (UNIST, Korea) AIM2 Inflammasome as a Double-Edged Sword in Viral Immunity |
| 11:40-13:00 | Lunch |
| Symposium 2 / Chairs: Dr. Peiris, Joseph Sriyal Malik, Dr. Jae Ung Jung | |
| 13:00-13:40 | Dr. Richard Webby (St. Jude Children’s Research Hospital, USA) A(H5N1) influenza viruses in the Americas |
| 13:40-14:10 | Min-Suk Song (Chungbuk National University, Korea) TBA |
| 14:10-14:40 | Dr. Yong Taik Lim (Sungkyunkwan University, Korea) Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models |
| 14:40-15:10 | Dr. Rajendra Karki (Seoul National University, Korea) Innate Immune Recognition of DAMPs and PAMPs in Liver Disease Pathogenesis |
| 15:10-15:40 | Coffee Break |
| Symposium 3 / Chairs: Dr. Jin Hyun Ahn, r. Moon Jung Song | |
| 15:40-16:20 | Dr. Jae Ung Jung (Cleveland Clinic, USA) Bunyavirus Therapeutics and Vaccines |
| 16:20-16:50 | Dr. Benjamin Brennan (University of Glasgow, UK) SFTSV NSs as a molecular determinant of infection in tick cell cultures |
| 16:50-17:20 | Dr. Nam-hyuk Cho (Seoul National University, Korea) Vaccine development for Severe Fever with Thrombocytopenia Syndrome |
| 17:20-17:50 | Dr. Jong-Eun Park (Korea Advanced Institute of Science and Technology, Korea) Lifetime dynamics of immune cells and the immune repertoire revealed by integrative single-cell analysis |
| Time | Program |
|---|---|
| Symposium 4 / Chairs: Dr. Young Ki Choi, Dr. Jong-Eun Park | |
| 09:30-10:10 | Dr. V. Narry Kim (Institute for Basic Science, Seoul National University, Korea) Exploring the Virosphere to Uncover Hidden Mechanisms |
| 10:10-10:40 | Dr. Jin Hyun Ahn (Sungkyunkwan University, Korea) G-quadruplex regulation of cytomegalovirus infection |
| 10:40-11:10 | Dr. Moon Jung Song (Korea University, Korea) The Molecular Gatekeepers: NLRC3 and G-quadruplex Dynamics in Controlling Oncogenic Herpesvirus Latency in B Cells |
| 11:10-11:40 | Dr. Heeju Ryu (Sungkyunkwan University, Korea) High-dimensional profiling of virus-specific T cells in virus-associated caner and infection |
| 11:40-13:00 | Lunch |
| Symposium 5 | |
| 13:00-13:40 | Dr. Arash Grakoui (Emory University, USA) Inducible Hepatic-Associated Lymphoid Tissue (iHALT): liver as a surrogate secondary lymphoid organ in hepatotropic viral infection |
| 13:40-14:10 | Dr. Seung-Woo Lee (Pohang University of Science and Technology, Korea) Epithelial antigen presentation promotes lung regeneration after influenza virus infection |
| 14:10-14:40 | Dr. Min Kyung Jung (Korea Virus Research Institute, IBS, Korea) CD8+ T cell differentiation landscapes after COVID-19 vaccination |
| 14:40-15:10 | Dr. Yeonseok Chung (Seoul National University, Korea) Metabolic Control of Humoral Immunity |
| 15:10-15:40 | Coffee Break |
| 15:40-16:10 | Dr. Masanori Isogawa (National Institute of Infectious Diseases, Japan) Distinct Localization of Cytotoxic and Cytokine-producing CD8+ T Cells in the Liver during OX40-mediated Virus Inactivation |
| 16:10-16:40 | Dr. You-Me Kim (Korea Advanced Institute of Science and Technology, Korea) Latent CMV infection and MASH |
| 16:40-17:10 | Dr. Bertram Bengsch (University of Freiburg, Germany) Novel insights into virus-specific CD8 T cells in chronic viral hepatitis |
| 17:10-17:40 | Dr. Eui-Cheol Shin (Korea Advanced Institute of Science and Technology, Korea) Regulation of IL-15-induced NK-like activation of CD8+ T cells in viral infection |
Invited Speakers
Plenary Speakers
Invited Speakers
Biography
Professor and Chair
Cleveland Clinic
jungj@ccf.org
Prof. Jung is currently Betsy B. deWindt Professor, Chair of Cancer Biology Department, Director of Infection Biology Program, and Director of Global Center for Pathogen and Human Health Research at Lerner Research I nstitute, Cleveland Clinic.
Originally from South Korea, Prof. Jung began his career as a fellow and later a tenured professor of Microbiology and Molecular Genetic at Harvard Medical School and served as Chair of the Tumor Virology Division (1989-2007). Dr. Jung transitioned to University of Southern California, assuming the roles of Fletcher Jones Foundation Endowed Chair, Distinguished Professor, Chair of the Molecular Microbiology and Immunology Department, and Director of the USC Institute of Emerging Pathogens and Immune Diseases at the Keck School of Medicine (2007-2020).
Prof. Jung has been awarded South Korea’s 2012 Ho-Am Prize in Medicine. He is Fellow of American Academy of Microbiology and Fellow of American Association for the Advancement of Science. He was a recipient of the Scholar Award of the Leukemia and Lymphoma Society of America, Howard T. Ricketts Lecture Award, Dr. Windsor and Mary Cutting Lecture Award, and the National Institute of Cancer Outstanding Investigator Award.
He received the B.S. degree (1982) and M.S. degree (1984) from the department of the Food Science at Seoul National University, Korea. He then received Ph.D. degree from the department of Microbiology at University of California-Davis in 1989.
Biography
Biography
Biography
Biography
Abstract
This content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Biography
Professor Young Ki Choi, DVM, Ph.D
Professor, College of Medicine, Chungbuk National University, Korea
Managing Director, Korea Virus Research Institute KVRI), Institute for Basic Science (IBS), Korea
Director, Centre for Emerging and Re-emerging Viral Diseases (KVRI), Korea
E-mail: choiki55@ibs.re.kr
Tel (office): +82-42-878 8350
Professor Choi obtained his B.S. and M.S. from the College of Veterinary Sciences at Chungnam National University and received a Ph.D. in Virology at the University of Minnesota. During his post-doc fellowship under the mentorship of Dr. Robert Webster at St. Jude Children’s Research Hospital, he experienced many laboratory and field studies on highly pathogenic zoonotic viral diseases. He has served as a professor at Chungbuk National University’s College of Medicine, where he researched the pathogenic mechanisms by which viruses infect hosts and vaccine development. His recent studies on SFTSV and COVID-19 have garnered much attention at home and abroad, which include establishing the animal models of virus infections and transmissions. From July 2021, he has been conducting research on Emerging and re-emerging viral diseases as the managing director at the Korea Virus Research Institute in the Institute of Basic Science (IBS).
Education / Career
2021.07-present. Managing Director, Korea Virus Research Institute. Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea
2024.09- 2023.10. Professor, Chungbuk National University, Korea
2003-2004.08. Post-doctoral fellow, St. Jude Children’s Research Hospital, USA
Ph.D. (2002). University of Minnesota, USA.
Bs, Master. (1999) College of Veterinary Medicine, Chung-Nam National University, South Korea.
Selected Publications List
- Ferrets animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis. Park SJ, et al. Nature Microbiol, 4(3):438-446, 2019.
- Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model. Yu KM, et al. Proc Natl Acad Sci U S A, Vol 116, no 52 26, 26900-26908, 2019
- Development of an SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets. Kwak JE, et al. Nature Commun, 23;10(1):3836, doi:
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Kim YI, et al. Cell Host Microbe, 5, pii: S1931-3128(20)30187-6, 202010.1038/s41467-019-11815-4, 2019.
- A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein. Kim C, et al. Nat Commun, 12;12(1):288, doi: 10.1038/s41467-020-20602-5, 2021.
- Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets. Lee JS, Koh JY, Yi K, Kim YI, et al, Nat Commun. 2021 Jul 27;12(1):4567. doi: 10.1038/s41467-021-24807-0.
- Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets. Kim YI, Yu KM, Koh JY, et al, Nat Commun. 2022 Jan 10;13(1):21. doi: 10.1038/s41467-021-27717-3.
Biography
SangJoon Lee
Assistant Professor
Department of Biological Science, UNIST, Republic of Korea
sangjoon.lee@unist.ac.kr
Professor SangJoon Lee commenced his research career during his doctoral studies at the University of Tsukuba (Japan), investigating innate immunity against influenza infection. He subsequently undertook postdoctoral fellowships at the University of Tsukuba and St. Jude Children’s Research Hospital (USA), focusing on innate immunity against various viral infections and a form of cell death known as PANoptosis.
In 2022, Professor Lee assumed the role of Assistant Professor in the Department of Biological Science at the Ulsan National Institute of Science and Technology (UNIST), where his research has centered on inflammasomes and inflammatory cell death in the context of innate immunity, infectious diseases, inflammatory disorders, and cancer.
Throughout his career, Professor Lee has been the recipient of numerous prestigious awards and honors, including the HBP Fellow Award in 2013 (University of Tsukuba), the Outstanding Research Award (University of Tsukuba) in 2019, the Yuhan Innovation Program Award (Yuhan Corporation) in 2022, and appointment as Director of the UNIST Pandemic Research Center in 2023 (The Circle Foundation).
Biography
Yong Taik Lim
Professor
Sungkyunkwan University
yongtaik@skku.edu
Prof. LIM is currently a Professor at the Department of Nano Engineering and SKKU Advanced Institute of Nanotechnology in Sungkyunkwan University (SKKU), Suwon, Korea. His research field of interest is Immuno-Bio-Engineering for Cancer Immunotherapy and Infectious Disease. He is developing designer biopharmaceuticals for cancer immunotherapy and vaccine adjuvants for infectious disease.
After he received his Ph.D. degree at the Department of Chemical and Biomolecular Engineering in the Korea Advanced Institute of Science and Technology (KAIST) in 2002, he joined John V. Franginoni’s laboratory at Harvard Medical School as a postdoctoral research fellow. He also worked about 5 years at the two Korea government-supported research institutes (ETRI and KRIBB) as an alternative military service. He started professorship at Chungnam National University in 2009 and moved to Sungkyunkwan University in 2014.
He received the B.S. degree from the department of the Chemical Engineering at the Sogang University, Korea in 1996. He then received the M.S. degree from the department of Chemical and Biomolecular Engineering at the Korea Advanced Institute of Science and Technology (KAIST) in 1998 and Ph.D. at KAIST in 2002.
Biography
Nam-Hyuk Cho
Professor
Seoul National University College of Medicine
chonh@snu.ac.kr
Dr. Nam-Hyuk Cho has a longstanding interest in host-pathogen interactions, particularly in emerging human pathogens. He received the B.S. degree from the department of the genetic engineering at the Korea University in 1996. He then received the M.S. degree from the graduate school of biotechnology at the Korea University in 1998 and Ph.D. degree from the department of Microbiology and Immunology at the Seoul National University College of Medicine in 2001.
He is currently a professor in the Department of Microbiology and Immunology at Seoul National University College of Medicine, Seoul, South Korea. Dr. Cho began studying immune responses and immunopathogenesis during the infection of Orientia tsutsugamushi, the causative agent of scrub typhus, during his Ph.D. training at Seoul National University. He expanded his research areas to virology while undergoing postdoctoral training at Harvard Medical School. Dr. Cho has a broad background in cellular immunology, molecular biology, microbiology, and virology. He has collaborated with clinicians in several Korean hospitals to study the immunological pathogenesis of several endemic and new emerging infectious diseases, including scrub typhus, severe fever with thrombocytopenia syndrome (SFTS), and emerging coronavirus infections.
Dr. Cho’s team has been exploring potential antigens for vaccine development through animal model studies and clinical research on scrub typhus. Additionally, their research extends to virus-host cell interactions, particularly with emerging viral pathogens such as SFTSV, MERS-CoV, and SARS-CoV-2. By elucidating the fundamental mechanisms utilized by these emerging human pathogens, his work aims not only to contribute to effective strategies against severe infections but also to offer insights into the evolutionary development of our immune system. The ultimate objective of Dr. Cho’s research is the artificial engineering of immune structures through immunoarchitectonic approach, which aims to regulate our immune response to a variety of human diseases, including infections and cancers.
Biography
Prof. Eui-Cheol Shin received his M.D. (1996) and Ph.D. (2001) from Yonsei University College of Medicine, Seoul, Republic of Korea, and his postdoctoral training from NIDDK, National Institutes of Health, Bethesda, Maryland, USA. Then he joined Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea in 2007, where he is currently a professor. He also serves as the director of the Center for Viral Immunology, Korea Virus Research Institute, Institute for Basic Science (IBS), Daejeon, Republic of Korea, since 2021. His laboratory performs researches on T cell responses in human viral disease and cancer. In particular, he currently focuses on ‘T cell-mediated immunopathogenesis’, ‘senescence of T cells’, ‘reinvigoration of exhausted T cells’, and ‘immune responses in SARS-CoV-2 infection and COVID-19’. Prof. Shin was elected as a member of The Korea Academy of Science and Technology and The National Academy of Medicine of Korea in 2019 and 2024, respectively.
Biography
Biography
Min-Suk Song
Professor
Chungbuk National University
songminsuk@chungbuk.ac.kr
Min-Suk Song, Ph.D., is currently a Professor at the College of Medicine and Medical Research Institute at Chungbuk National University in Cheongju-si, Korea. He specializes in microbiology with a focus on the pathogenesis of influenza viruses and the development of vaccines for infectious diseases.
Dr. Song began his academic journey at Chungbuk National University, earning his B.S. in Biology in 2006 and an M.S. in Microbiology in 2008. His master’s thesis, titled “Ecology of H3 Avian influenza viruses in Korea and assessment of their pathogenic potentials,” paved the way for his continued research in virology. He achieved his Ph.D. in 2011 with a thesis on the “Investigation of Pathogenic Determinants of Influenza Viruses in Mammalian and Their Molecular Characterizations.”
Following his doctorate, Dr. Song served as a postdoctoral research associate at the same institution from 2011 to 2012. He expanded his research horizons internationally as a postdoctoral research associate at St. Jude Children’s Research Hospital in the United States from 2013 to 2014. Returning to Chungbuk National University, he progressed from Assistant Professor in 2014 to Associate Professor in 2018, and was appointed full Professor in October 2023.
Dr. Song is leading a groundbreaking project focusing on the development of vaccines for infectious diseases using a capless self-amplifying RNA vaccine platform devised by his team. This innovative approach highlights his commitment to advancing medical research and public health.
He has been recognized for his contributions to virology and microbiology with several awards, including the Best Poster Presentation Award at the Options for the Control of Influenza VI Conference in Toronto in 2007 and the Most Valuable Paper Award at the 2016 TEPIK International Influenza Symposium.
Dr. Song is an active member of several professional societies, including The Korean Society for Microbiology and Biotechnology, The Korean Society of Virology, the American Society of Virology, and the Microbiology Society. His research continues to impact the field, focusing on molecular characterizations and pathogenic determinants of influenza viruses.
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Biography
Abstract
This content will be updated soon.
Abstract
This content will be updated soon.
Abstract
This content will be updated soon.
Abstract
This content will be updated soon.
Abstract
This content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Abstract
This Content will be updated soon.
Registration
Registration Period
October 13th – November 14th
Registration Fee
Student: 70,000 KRW
Regular: 100,000 KRW
Notice
Registration will be open soon.
Please try later.
Organizers
Host
Sponsor
To be announced
Venue
2F, Grand Ballroom, Daejeon Convention Center 1 (DCC 1), Daejeon, South Korea
107 Expo-ro, Yuseong-gu, Daejeon, South Korea, 34125